New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to previous years, but still well outpacing price increases of other common household goods.
Similarly, Reuters reports that prices of more than 250 prescription drugs have already gone up in January, with additional increases expected to be announced later this month.
Pharmaceutical company spokespersons cited multiple explanations for the price increases, including operational expenses and the need to offset payer rebates and discounts. But whatever the reason, it’s clear that drug prices will continue to rise disproportionally for the foreseeable future.
MedBen Rx offers pharmaceutical solutions that help employers to avoid the artificial pricing markups that allow for the so-called discounts… an approach that in no way reflects the real cost of the drug.
Regardless of your business type, MedBen Rx offers a pricing strategy that will work with your pharmacy plan to ensure that you pay less. And we feature a variety of benefits management services that further your cost saving potential.
Find out more about how MedBen Rx can help you beat drug pricing trends by contacting Vice President of Sales & Marketing Brian Fargus at 888-627-8683 or firstname.lastname@example.org.